<DOC>
	<DOCNO>NCT02627625</DOCNO>
	<brief_summary>The purpose study compare absorption three different inhalation product reference product healthy volunteer .</brief_summary>
	<brief_title>Comparison Pharmacokinetics Tiotropium Delivered From Test Inhaler Products With Two Reference Products</brief_title>
	<detailed_description>Healthy subject enrol receive single dose 3 test inhalation product two reference inhalation product accord five-period cross-over design . Plasma tiotropium level measure pre-dose 8 hour post-dose .</detailed_description>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Healthy Volunteer Willing able give inform consent Willing withhold alcoholic beverage 48 hour xanthine contain food beverages 24 hour prior report clinic Subjects must agree use adequate method contraception admission 12 week last administration Evidence history clinically significant abnormality disease chronic respiratory disorder Any presence history clinically significant allergy include adverse reaction study drug History drug alcohol abuse within past 2 year Smoked tobacco within past 6 month history 10 pack year ( number pack smoke per day x number year smoke ) Donation loss great 400 mL blood within previous 3 month Have receive prescription medication within 4 week investigational medication within 12 week study ( exception : contraceptive permit ) Have receive nonprescription medication within 14 day prior dose ( exception : paracetamol use within 2 day ) Upper respiratory tract infection ( exclude otitis medium ) within 14 day first study day , low respiratory tract infection within last 3 month If female , nursing , lactate pregnant Regular alcohol consumption male &gt; 21 unit per week female &gt; 14 unit per week ( 1 unit = Â½ pint beer , 25 mL 40 % spirit 125 mL glass wine )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>inhalation</keyword>
	<keyword>anticholinergic</keyword>
</DOC>